Evidence map›Paper›PMID 20362509›Full record

ReviewTrends in immunology2010

Advances in lupus stemming from the parent-into-F1 model.

Charles S Via

Abstract readReview
In one paragraph

Review in Trends in immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. In vivo IL-4 prevents allo-antigen driven CD8Clinical immunology (Orlando, Fla.) · 2017
    Article
  11. Article
  12. T cell CD3ζ deficiency enables multiorgan tissue inflammation.Journal of immunology (Baltimore, Md. : 1950) · 2013
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Murine models of systemic lupus erythematosus.Journal of biomedicine & biotechnology · 2011
    Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Charles S ViaPathology Department, Uniformed Services University of Health Sciences, Bethesda, MD 21042, USA. cvia@usuhs.mil

Funding

IMMUNOPATHOGENESIS OF LUPUSR01AI047466 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VIA, CHARLES S. · 2001 to 2012
$3.2M
Immunopathogenesis of LupusR56AI047466 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI VIA, CHARLES S. · 2014 to 2014
$189k
NIAID NIH HHS AI047466NIAID NIH HHS R01 AI047466NIAID NIH HHS R56 AI047466
6 · The paper itself

Abstract

The parent-into-F1 model has led to important advances in our understanding of lupus. Here, we review the work in murine lupus that elucidated the role of T cells and supported the conclusion that the parent-into-F1 model of induced lupus compares favorably with de facto gold standard spontaneous models of lupus. Then we focus on recent work in parent-into-F1 mice, which has yielded novel insights into unresolved controversies, such as the role of apoptosis in the pathogenesis of lupus and lupus in patients receiving TNF blockade. Finally, the review considers the evidence that supports a potential role for CD8 T cells, both cytotoxic and memory cells, in mediating disease remission.

Indexed as

AnimalsCD8-Positive T-LymphocytesDisease Models, AnimalDisease SusceptibilityGraft vs Host DiseaseHumansImmunologic MemoryLupus Erythematosus, SystemicMice

Identifiers

PMID20362509
PMCPMC2883015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.